NACDS TSE 2026 Event Recap
NACDS TSE 2026 in Boston was nothing short of amazing! From connecting with customers and partners to exploring the tradeshow floor and catching up with familiar faces, the event was filled with meaningful conversations, new opportunities, and plenty of Camber spirit.
With 100+ meetings, Team Camber connected with both current and prospective partners to discuss our growing product portfolio, pipeline, and the exciting things happening across the company. Each conversation provided an opportunity to strengthen relationships, learn more about our customers’ needs, and share how Camber continues to deliver access and value to the healthcare industry.
“NACDS TSE continues to be an incredible opportunity for Camber to connect with our customers, strengthen relationships, and showcase the momentum we have across the business,” said Kon Ostaficiuk, President of Camber Pharmaceuticals. “The conversations we had in Boston reinforced the strength of our partnerships and the exciting opportunities ahead for Camber.”
Our Rx sales team met with longtime customers and new partners to hold productive conversations regarding our evolving industry. “These face-to-face interactions are invaluable as we work together to better understand customer needs and identify opportunities to grow our partnerships,” said Scott Hettenhausen, VP of Rx sales.
NACDS TSE 2026 was a great reminder of the importance of collaboration and the strong relationships that continue to drive our business forward. We are grateful to everyone who took the time to meet with Team Camber and make this year’s event such a success.
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






